Recent Mergers and Acquisitions
Celgene Corporation merger with Bristol-Myers Squibb
Celgene Corporation, an immunology pharmaceutical company, merged with Bristol-Myers Squibb (NYSE: BMY), a prescription-manufacturing pharmaceutical company, in a transaction valued at $74 billion.
Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.
Find more information here.
Topics
Celgene Corporation merger with Bristol-Myers Squibb
Topics
Celgene Corporation, an immunology pharmaceutical company, merged with Bristol-Myers Squibb (NYSE: BMY), a prescription-manufacturing pharmaceutical company, in a transaction valued at $74 billion.
Morrow Sodali acted as the proxy solicitor for the bidder in this transaction.
Find more information here.